Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Debt / NOTE 4.750% 5/0
-
Market price (% of par)
-
80.67%
-
Total 13F principal
-
$89,469,000
-
Principal change
-
-$5,121,000
-
Total reported market value
-
$68,481,000
-
Number of holders
-
11
-
Value change
-
-$4,741,574
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of PARATEK PHARMACEUTICALS INC - NOTE 4.750% 5/0 as of Q2 2020
As of 30 Jun 2020 PARATEK PHARMACEUTICALS INC - NOTE 4.750% 5/0 had 11 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $89,469,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, MACQUARIE GROUP LTD, CAPSTONE INVESTMENT ADVISORS, LLC, WELLS FARGO & COMPANY/MN, PALISADE CAPITAL MANAGEMENT LLC/NJ, CNH PARTNERS LLC, BANK OF AMERICA CORP /DE/, GABELLI FUNDS LLC, and Teton Advisors, Inc..
This table shows 11 bond principal holders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par) |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.